Products | Polpharma API

Generics

We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements  of EDQM (CEP), ICH (ASMF in eCTD format), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.

Search for product

a b c d e f g h i j k l m n o p r s t u v x y z

Filters

Commercial

Pipeline

Musculo-skeletal system

Alimentary tract & metabolism Antifungal agent Anti-infectives for systemic use Antipyretic, analgesic and anti-inflammatory Antineoplastic & immunomodulating agents Blood & blood forming organs Cardiovascular system Genito-urinary system & sex hormones Injectable Forms Nervous system Opthalmological preparations Respiratory system Oncology

Available EU DMF/CEP/US DMF

EU DMF CEP US DMF

Injectable Forms

Yes No

Reset filters

API product & pipeline (pdf)

Sort by

Alphabetical Therapeutic Category

Sort:

Alphabetical Therapeutic Category

Status

Therapeutic Category

Polymorphic form

CAS No.

A

Alendronate sodium

StatusCommercial

Therapeutic CategoryMusculo-skeletal system

Polymorphic formTrihydrate

CAS No.121268-17-5
View more

B

Baclofen

StatusCommercial

Therapeutic CategoryMusculo-skeletal system

Polymorphic formForm B

CAS No.1134-47-0
View more

E

Etodolac

StatusCommercial

Therapeutic CategoryMusculo-skeletal system

Polymorphic formCrystalline racemate, none

CAS No.41340-25-4
View more

I

Ibandronate sodium

StatusCommercial

Therapeutic CategoryMusculo-skeletal system

Polymorphic formMonohydrate Form B

CAS No.138926-19-9
View more

R

Risedronate sodium

StatusCommercial

Therapeutic CategoryMusculo-skeletal system

Polymorphic formForm A

CAS No.329003-65-8
View more

Z

Zoledronic acid

StatusCommercial

Therapeutic CategoryMusculo-skeletal system

Polymorphic formMonohydrate

CAS No.165800-06-6
View more